Stages of biomarker discovery from identifying targets (Step 1) to clinical benefit verification (Step 4). Click here for further information.
Click here: Explore Biomarkers in Schizophrenia
Related content
Why is there a mortality gap in schizophrenia?
Dr. Marco Solmi introduces what the mortality gap is and why there is a mortality gap in schizophrenia.
24.03.2026
Schizophrenia
Physical Health in Mental Disorders: Burden and Solutions
Physical health and mental disorders are closely linked, with mental–physical comorbidity posing a major global public health and equity challenge.
12.03.2026
Schizophrenia
Main organ systems affected by physical comorbidities in people with mental disorders
Across mental disorders, physical comorbidities commonly affect multiple organ systems, most notably cardiometabolic and respiratory systems.
12.03.2026
Schizophrenia